Has Matthew Thibodeaux, OD received payments from drug or device companies?

Yes. Drug and device makers reported $4,865 in general payments to Matthew Thibodeaux, OD across 108 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Thibodeaux, OD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Thibodeaux, OD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Thibodeaux, OD

Optometrist · Boutte, LANPI 1194249086

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,502, 8.8 times the $171 reported in 2019.

$4,865in general payments, 2019–2025

Across 108 payments — averaging $45.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Alcon$1K
Bausch & Lomb Americas Inc.$885
Johnson & Johnson Vision Care, Inc.$821
Biotissue Holdings Inc.$446
Bausch & Lomb, A Division Of Bausch Health US, LLC$367
Harrow Eye, LLC$200
plus $1K from 12 others

What the payments were for

Food & beverage$4,865100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Alcon	34	$1,014
Bausch & Lomb Americas Inc.	17	$885
Johnson & Johnson Vision Care, Inc.	12	$821
Biotissue Holdings Inc.	5	$446
Bausch & Lomb, A Division Of Bausch Health US, LLC	8	$367
Harrow Eye, LLC	4	$200
Mallinckrodt Hospital Products Inc.	4	$192
Optos, Inc.	1	$191
Oyster Point Pharma, Inc.	5	$136
Kala Pharmaceuticals, Inc.	1	$122
Coopervision Inc.	2	$112
AbbVie(2 entities)	3	$101
Tarsus Pharmaceuticals, Inc.	3	$72
Glaukos Corporation	2	$58
Dompe US, Inc.	2	$54
Novartis	3	$52
Apellis Pharmaceuticals, Inc.	1	$27
Sun Pharmaceutical Industries Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,865 in reported general payments places this provider in the 85th percentile of 500 optometrist providers in Louisiana.

See all optometrist providers in Louisiana →

Medicare billing

Part B allowed, 2024

$25,068

Medicare patients

164

Services billed

300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tobramycin-DexamethasoneTobramycin/Dexamethasone	145	$6,885
Prednisolone Acetate	21	$714
Doxycycline Monohydrate	42	$481
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha	21	$303
Latanoprost	38	$222
Doxycycline Hyclate	19	$163
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	12	$115
Timolol Maleate	17	$100
Triamcinolone Acetonide	12	$47

Paid to pharmacies, not to this prescriber.

Other optometrist in Boutte

Pamela TheriotShreveport$207K
Joshua DavidsonGonzales$189K
Jeffrey WilhiteMarrero$86K
Christopher WrotenHammond$59K
James LamarNew Orleans$45K
John McCallLogansport$32K
Robert KellyMarrero$26K
Shane FontenotJennings$23K
Stephen LewisShreveport$17K
Breanne McGheeNew Orleans$14K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →